Advertisement
Screener

CHINA PHARMA HOLDINGS, INC. (CPHI) Cash and Cash Equivalents, Period Increase (Decrease)

0.9 / 5 stars · 18/95 Roast Me

CHINA PHARMA HOLDINGS, INC. Cash and Cash Equivalents, Period Increase (Decrease)

CHINA PHARMA HOLDINGS, INC. (CPHI) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$424.98 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-11-14

  • CHINA PHARMA HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$894.29K.
  • CHINA PHARMA HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $694.62K.
  • CHINA PHARMA HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$225.31K, a 151.46% decline year-over-year.
  • CHINA PHARMA HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $518.96K, a 42.71% decline year-over-year.
  • CHINA PHARMA HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$843.63K.
  • CHINA PHARMA HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$635.59K.
  • CHINA PHARMA HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$3.58M, a 475.98% decline from fiscal 2015.
  • CHINA PHARMA HOLDINGS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $952.97K.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 3 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2019-09-30-$894.29K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$199.67K
derived: sum of 2 quarters · filed 2019-11-14
-$424.98K
10-Q · filed 2019-11-14
$93.98K
derived: sum of 4 quarters · filed 2019-11-14
2019-06-30$694.62K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$469.31K
10-Q · filed 2019-08-14
$988.26K
derived: sum of 3 quarters · filed 2019-08-14
-$279.63K
derived: sum of 4 quarters · filed 2019-11-14
2019-03-31-$225.31K
10-Q · filed 2019-05-14
$293.65K
derived: sum of 2 quarters · filed 2019-05-14
-$974.25K
derived: sum of 3 quarters · filed 2019-11-14
-$1.51M
derived: sum of 4 quarters · filed 2019-11-14
2018-12-31$518.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28
-$748.94K
derived: sum of 2 quarters · filed 2019-11-14
-$1.28M
derived: sum of 3 quarters · filed 2019-11-14
-$843.63K
10-K · filed 2019-03-28
2018-09-30-$1.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$1.80M
derived: sum of 2 quarters · filed 2019-11-14
-$1.36M
10-Q · filed 2019-11-14
-$456.81K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$532.51K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$94.69K
10-Q · filed 2019-08-14
$811.09K
derived: sum of 3 quarters · filed 2019-08-14
$189.96K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$437.82K
10-Q · filed 2019-05-14
$1.34M
derived: sum of 2 quarters · filed 2019-05-14
$722.47K
derived: sum of 3 quarters · filed 2019-05-14
-$55.51K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$905.77K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28
$284.65K
derived: sum of 2 quarters · filed 2019-03-28
-$493.33K
derived: sum of 3 quarters · filed 2019-03-28
-$635.59K
10-K · filed 2019-03-28
2017-09-30-$621.13K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$1.40M
derived: sum of 2 quarters · filed 2018-11-14
-$1.54M
10-Q · filed 2018-11-14
-$2.53M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$777.98K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
-$920.24K
10-Q · filed 2018-08-14
-$1.90M
derived: sum of 3 quarters · filed 2018-08-14
-$4.54M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$142.26K
10-Q · filed 2018-05-14
-$1.13M
derived: sum of 2 quarters · filed 2018-05-14
-$3.76M
derived: sum of 3 quarters · filed 2018-05-14
-$4.74M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31-$984.24K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
-$3.62M
derived: sum of 2 quarters · filed 2018-04-02
-$4.60M
derived: sum of 3 quarters · filed 2018-04-02
-$3.58M
10-K · filed 2018-04-02
2016-09-30-$2.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$3.61M
derived: sum of 2 quarters · filed 2017-11-14
-$2.60M
10-Q · filed 2017-11-14
-$2.07M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30-$976.54K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$36.48K
10-Q · filed 2017-08-14
$567.73K
derived: sum of 3 quarters · filed 2017-08-14
$1.76M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$1.01M
10-Q · filed 2017-05-11
$1.54M
derived: sum of 2 quarters · filed 2017-05-11
$2.74M
derived: sum of 3 quarters · filed 2017-05-11
$1.99M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$531.25K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
$1.72M
derived: sum of 2 quarters · filed 2017-03-31
$979.90K
derived: sum of 3 quarters · filed 2017-03-31
$952.97K
10-K · filed 2017-03-31
2015-09-30$1.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$448.65K
derived: sum of 2 quarters · filed 2016-11-14
$421.72K
10-Q · filed 2016-11-14
$1.45M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30-$743.86K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
-$770.79K
10-Q · filed 2016-08-11
$255.96K
derived: sum of 3 quarters · filed 2016-08-11
$99.26K
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31-$26.93K
10-Q · filed 2016-05-16
$999.82K
derived: sum of 2 quarters · filed 2016-05-16
$843.11K
derived: sum of 3 quarters · filed 2016-05-16
-$23.10K
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$870.05K
derived: sum of 2 quarters · filed 2016-03-30
$3.83K
derived: sum of 3 quarters · filed 2016-03-30
-$697.35K
10-K · filed 2016-03-30
2014-09-30-$156.71K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-28
-$1.02M
derived: sum of 2 quarters · filed 2015-12-28
-$1.72M
10-Q · filed 2015-12-28
-$236.46K
derived: sum of 4 quarters · filed 2015-12-28
2014-06-30-$866.22K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28
-$1.57M
10-Q · filed 2015-12-28
-$79.75K
derived: sum of 3 quarters · filed 2015-12-28
$1.90M
derived: sum of 4 quarters · filed 2015-12-28
2014-03-31-$701.18K
10-Q · filed 2015-12-28
-$491.57K
10-Q · filed 2014-05-15
$786.46K
derived: sum of 2 quarters · filed 2015-12-28
$2.77M
derived: sum of 3 quarters · filed 2015-12-28
$1.85M
derived: sum of 4 quarters · filed 2015-12-28
2013-12-31$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28
$3.47M
derived: sum of 2 quarters · filed 2015-12-28
$2.55M
derived: sum of 3 quarters · filed 2015-12-28
$1.96M
10-K · filed 2015-12-28
2013-09-30$1.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$1.06M
derived: sum of 2 quarters · filed 2014-11-14
$475.79K
10-Q · filed 2014-11-14
-$556.27K
derived: sum of 4 quarters · filed 2014-11-14
2013-06-30-$921.25K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
-$1.51M
10-Q · filed 2014-08-14
-$2.54M
derived: sum of 3 quarters · filed 2014-08-14
-$2.35M
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31-$583.94K
10-Q · filed 2014-05-15
$720.76K
10-Q · filed 2013-05-14
-$1.62M
derived: sum of 2 quarters · filed 2014-05-15
-$1.43M
derived: sum of 3 quarters · filed 2014-05-15
$125.97K
derived: sum of 4 quarters · filed 2014-05-15
2012-12-31-$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20
-$841.84K
derived: sum of 2 quarters · filed 2014-03-20
$709.90K
derived: sum of 3 quarters · filed 2014-03-20
-$21.15K
10-K · filed 2014-03-20
2012-09-30$190.22K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
$1.74M
derived: sum of 2 quarters · filed 2013-11-14
$1.01M
10-Q · filed 2013-11-14
$209.03K
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30$1.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$820.70K
10-Q · filed 2013-08-14
$18.81K
derived: sum of 3 quarters · filed 2013-08-14
$183.89K
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31-$731.05K
10-Q · filed 2013-05-14
-$1.53M
derived: sum of 2 quarters · filed 2013-05-14
-$1.37M
derived: sum of 3 quarters · filed 2013-05-14
-$483.84K
derived: sum of 4 quarters · filed 2013-05-14
2011-12-31-$801.89K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
-$636.80K
derived: sum of 2 quarters · filed 2013-03-14
$247.21K
derived: sum of 3 quarters · filed 2013-03-14
$358.77K
10-K · filed 2013-03-14
2011-09-30$165.08K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
$1.05M
derived: sum of 2 quarters · filed 2012-11-14
$1.16M
10-Q · filed 2012-11-14
$291.31K
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$884.01K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$995.57K
10-Q · filed 2012-08-14
$126.22K
derived: sum of 3 quarters · filed 2012-08-14
$159.54K
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31$111.56K
10-Q · filed 2012-05-14
-$757.79K
derived: sum of 2 quarters · filed 2012-05-14
-$724.47K
derived: sum of 3 quarters · filed 2012-05-14
2010-12-31-$869.35K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14
-$836.03K
derived: sum of 2 quarters · filed 2012-03-14
$57.33K
10-K · filed 2012-03-14
2010-09-30$33.32K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06
$926.68K
10-Q/A · filed 2012-03-06
2010-06-30$893.36K
10-Q/A · filed 2011-09-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
NANOVIRICIDES, INC. (NNVC)United States$0.031B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30